Applied Finance IVS US SMID ETF
IVSS - ETF AI Analysis
Top Page
Applied Finance IVS US SMID ETF (IVSS)
IVSS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 29.97M
- Region
- North America
- Expense Ratio
- 0.59%
- Beta
- 0.57
- Issuer
- Applied Finance
- Inception Date
- Dec 03, 2025
- Dividend Yield
- 0.06%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
IVSS Summary
IVSS is an actively managed ETF that focuses on smaller and mid-sized U.S. companies, using an “intrinsic value” approach to pick stocks it believes are undervalued. It doesn’t track a traditional index, but instead targets the extended U.S. market across many sectors, including technology, health care, and financials. Well-known holdings include InterDigital and Healthequity. Investors might consider IVSS for growth potential and added diversification beyond large, well-known companies. However, because it invests in smaller firms and is actively managed, its price can be more volatile and can go up and down with the market.
How much will it cost me?
The Applied Finance IVS US SMID ETF (IVSS) has an expense ratio of 0.59%, meaning you’ll pay $5.90 per year for every $1,000 invested. This is higher than average because it’s an actively managed fund, which typically involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?
The Applied Finance IVS US SMID ETF (IVSS) could benefit from strong growth in small- and mid-cap U.S. companies, particularly in sectors like Technology and Consumer Cyclical, which are well-represented in its portfolio. However, it may face challenges from rising interest rates or economic slowdowns, which can negatively impact smaller companies and growth-oriented sectors. Additionally, its focus on the U.S. market makes it sensitive to domestic economic conditions and regulatory changes.
IVSS Top 10 Holdings
IVSS leans into U.S. small and mid caps with a tech-and-finance flavor, and a few standout names are steering the ship. Sezzle and Dave have been rising over the year, acting like growth engines for the fund, even though their shorter-term moves are more mixed. InterDigital and TriNet have also been steady to rising, helping performance from the technology and business services side. On the flip side, PJT Partners has been lagging, weighing on financials, while Indivior’s recent slump has kept health care from fully pulling its weight.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 HQY | Healthequity | 1.74% | $518.36K | $8.57B | 11.74% | 76Outperform |
 PJT | PJT Partners | 1.57% | $467.82K | $3.80B | -11.68% | 71Outperform |
 SEZL | Sezzle Inc. | 1.48% | $442.31K | $5.05B | 157.68% | 80Outperform |
 IDCC | InterDigital | 1.45% | $431.63K | $7.35B | -25.08% | 76Outperform |
 SWX | Southwest Gas | 1.41% | $421.40K | $6.62B | 15.86% | 74Outperform |
 DAVE | Dave | 1.34% | $399.78K | $3.56B | 24.58% | 80Outperform |
 FTDR | frontdoor | 1.26% | $376.32K | $6.56B | 96.62% | 72Outperform |
 OTTR | Otter Tail | 1.23% | $365.77K | $3.29B | -6.92% | 77Outperform |
 BTSG | BrightSpring Health Services, Inc. | 1.20% | $356.63K | $13.36B | 105.98% | 67Neutral |
 TNET | TriNet Group | 1.19% | $353.74K | $3.05B | 20.66% | 58Neutral |
IVSS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IVSS, the sentiment is Neutral. The current price of 29.83 is below the 20-day moving average (MA) of 30.12, above the 50-day MA of 29.77, and above the 200-day MA of 28.66, indicating a neutral trend. The MACD of 0.17 indicates Positive momentum. The RSI at 46.76 is Neutral, neither overbought nor oversold. The STOCH value of 24.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IVSS.
IVSS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| IVSS | $29.83 | $32.00(7.27% Upside) | $29.97M | 0.59% | 68Neutral |
 OASC | $32.71 | $40.21(22.94% Upside) | $97.22M | 0.69% | 68Neutral |
 POMG | $26.58 | $32.46(22.13% Upside) | $69.70M | 0.68% | 66Neutral |
 MYLD | $32.86 | $37.30(13.51% Upside) | $53.83M | 0.62% | 68Neutral |
 BCSM | $24.30 | $30.44(25.31% Upside) | $35.82M | 0.75% | 58Neutral |
 BRSM | $24.91 | $30.55(22.65% Upside) | $26.79M | 0.38% | 66Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IVSS | Applied Finance IVS US SMID ETF | 29.83 | 4.61 | 18.28% | |
| OASC | OneAscent Small Cap Core ETF | 32.71 | 4.03 | 14.06% | |
| POMG | PRIMECAP Odyssey Discovery ETF | 26.58 | 1.06 | 4.15% | |
| MYLD | Cambria Micro and SmallCap Shareholder Yield ETF | 32.86 | 7.79 | 31.09% | |
| BCSM | Baron SMID Cap ETF | 24.30 | -0.01 | -0.03% | |
| BRSM | MFS Blended Research Small-Mid Cap ETF | 24.91 | -0.13 | -0.51% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.